Shengjie Guo

7PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
Comparative effectiveness of thermal ablation, radiotherapy, and surgery for adrenal metastases: a multi-institutional cohort study.

Lin Xie, XianDa Chen, Lei Zhong

|Jun 18, 2024
Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen.

Nan Ma, Yi-Xiang Gan, Yin-Yao Chao

|Dec 29, 2023
Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.

Lichao Wei, Zaishang Li, Shengjie Guo

|Sep 08, 2022
Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Pei Dong, Xinyue Zhang, Yulu Peng

|Nov 24, 2021
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

Zhiyong Li, Lijuan Jiang, Zhiling Zhang

|Aug 14, 2019
Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.

Shengjie Guo, Kai Yao, Xiaobo He

Pageof 2

Frequent Collaborators

2 joint publications

Hui Han

1 joint publications

Nan Ma

1 joint publications

Yi-Xiang Gan

1 joint publications

Yunlin Ye